BridgeBio Submits NDA to FDA for Encaleret for Individuals Living with ADH1
Go back to BridgeBio Submits NDA to FDA for Encaleret for Individuals Living with ADH1| (NASDAQ: BBIO) | Delayed: 69.06 +2.79 (4.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.27 | 52 Week High | $ | |||
| Open | $66.35 | 52 Week Low | $ | |||
| Day High | $69.50 | P/E | N/A | |||
| Day Low | $66.30 | EPS | $ | |||
| Volume | 769,152 | |||||
